help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiss, L. M.
Right arrow Articles by Warnke, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, L. M.
Right arrow Articles by Warnke, R. A.

American Journal of Pathology, Vol 118, 316-324, Copyright © 1985 by American Society for Investigative Pathology


REGULAR ARTICLES

Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas

LM Weiss, GS Crabtree, RV Rouse and RA Warnke

Fifty T-cell lymphomas, excluding mycosis fungoides and lymphoblastic lymphoma, were studied morphologically and immunohistochemically with a panel of monoclonal antibodies reactive with T-cell differentiation antigens in fresh frozen tissue. Histologically, 36% of the lymphomas were large-cell immunoblastic, 26% were diffuse large-cell, 22% were diffuse mixed small and large-cell, and 16% were monomorphic medium- sized-cell lymphomas. By immunologic studies, 64% of the lymphomas were of helper phenotype, 12% were of cytotoxic/suppressor phenotype, 8% expressed both helper and cytotoxic/suppressor suppressor antigenic markers, and 16% lacked detectable markers for either helper or cytotoxic/suppressor cells. There was no correlation between histologic category and immunophenotype. A common finding, and one which may prove to be helpful in the diagnosis of T-cell lymphomas, was the loss of one or more of the pan-T antigens Leu 1, 4, and 5 or the T-cell antigen Leu 9 in 32 cases. The expression of Leu 1 and Leu 9 was lost in 46% of cases, expression of Leu 4 was lost in 26%, and expression of Leu 5 was lost in 24%. About three-quarters of the lymphomas expressed Ia antigens.


This article has been cited by other articles:


Home page
BloodHome page
A. Attygalle, R. Al-Jehani, T. C. Diss, P. Munson, H. Liu, M.-Q. Du, P. G. Isaacson, and A. Dogan
Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10
Blood, January 15, 2002; 99(2): 627 - 633.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Facchetti, J. K. C. Chan, W. Zhang, A. Tironi, M. Chilosi, S. Parolini, L. D. Notarangelo, and L. E. Samelson
Linker for Activation of T Cells (LAT), a Novel Immunohistochemical Marker for T Cells, NK Cells, Mast Cells, and Megakaryocytes : Evaluation in Normal and Pathological Conditions
Am. J. Pathol., April 1, 1999; 154(4): 1037 - 1046.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Gisselbrecht, P. Gaulard, E. Lepage, B. Coiffier, J. Briere, C. Haioun, D. Cazals-Hatem, A. Bosly, L. Xerri, H. Tilly, et al.
Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas
Blood, July 1, 1998; 92(1): 76 - 82.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Society for Investigative Pathology.